P2RY12 and acute coronary syndrome: In patients with AF who required percutaneous coronary intervention(s) due to acute coronary syndrome, a combination of APT therapy using a P2Y12 inhibitor and OAC yielded a non-inferior number of ischemic events with fewer bleeding complications than triple antithrombotic therapy (dual APT therapy plus OAC) (2, 30, 31).